Iovance’s AMTAGVI (lifileucel) Receives US FDA Accelerated Approval for Advanced Melanoma

0
47
Iovance Biotherapeutics, Inc. announced that the US FDA has approved AMTAGVI suspension for intravenous infusion.
[nan]
Press Release